PCH

Polar Capital Holdings Portfolio holdings

AUM $20.7B
1-Year Est. Return 81.27%
This Quarter Est. Return
1 Year Est. Return
+81.27%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.7B
AUM Growth
+$1.68B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
309
New
Increased
Reduced
Closed

Top Buys

1 +$222M
2 +$196M
3 +$193M
4
TTMI icon
TTM Technologies
TTMI
+$176M
5
APP icon
Applovin
APP
+$153M

Top Sells

1 +$279M
2 +$216M
3 +$208M
4
SPOT icon
Spotify
SPOT
+$192M
5
CYBR icon
CyberArk
CYBR
+$172M

Sector Composition

1 Technology 48.6%
2 Financials 15.7%
3 Healthcare 14.87%
4 Communication Services 10.81%
5 Consumer Discretionary 5.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADSK icon
226
Autodesk
ADSK
$55.7B
$1.3M 0.01%
4,100
-14,700
IBP icon
227
Installed Building Products
IBP
$8.4B
$1.13M 0.01%
4,600
-9,150
IONQ icon
228
IonQ
IONQ
$17.6B
$953K ﹤0.01%
+15,500
ON icon
229
ON Semiconductor
ON
$24.6B
$947K ﹤0.01%
19,200
-73,300
MP icon
230
MP Materials
MP
$12.2B
$530K ﹤0.01%
7,900
-185,600
VC icon
231
Visteon
VC
$2.63B
$312K ﹤0.01%
2,600
-1,400
NTES icon
232
NetEase
NTES
$86.8B
$266K ﹤0.01%
1,750
-150
LFST icon
233
Lifestance Health
LFST
$2.82B
$120K ﹤0.01%
21,775
+3,525
STXS icon
234
Stereotaxis
STXS
$259M
$54.9K ﹤0.01%
17,665
GDRX icon
235
GoodRx Holdings
GDRX
$927M
$42.3K ﹤0.01%
10,000
-11,250
ALC icon
236
Alcon
ALC
$39.2B
-235,030
APD icon
237
Air Products & Chemicals
APD
$59.1B
-750
ATR icon
238
AptarGroup
ATR
$8.12B
-149,701
LOW icon
239
Lowe's Companies
LOW
$155B
-67,503
MLTX icon
240
MoonLake Immunotherapeutics
MLTX
$1.17B
-247,500
MMSI icon
241
Merit Medical Systems
MMSI
$4.74B
-383,272
NDAQ icon
242
Nasdaq
NDAQ
$57.4B
-90,534
NOW icon
243
ServiceNow
NOW
$135B
-385,780
NTNX icon
244
Nutanix
NTNX
$13B
-170,417
NVMI icon
245
Nova
NVMI
$13.2B
-259,781
TOST icon
246
Toast
TOST
$19.5B
-474,963
TWLO icon
247
Twilio
TWLO
$18.2B
-792,236
UNH icon
248
UnitedHealth
UNH
$304B
-92,842
VRNA
249
DELISTED
Verona Pharma
VRNA
-875,000
DAWN icon
250
Day One Biopharmaceuticals
DAWN
$1.1B
-2,109,177